Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex chromosome complement interacts with gonadal hormones in determining regional-specific neuroactive steroid levels in plasma, hippocampus, and hypothalamus. A study using the four core genotype mouse model.
Cioffi L, Grassi D, Diviccaro S, Caruso D, Pinto-Benito D, Arevalo MA, Garcia-Segura LM, Melcangi RC, Giatti S. Cioffi L, et al. Among authors: melcangi rc. J Steroid Biochem Mol Biol. 2024 Jul;241:106514. doi: 10.1016/j.jsbmb.2024.106514. Epub 2024 Mar 28. J Steroid Biochem Mol Biol. 2024. PMID: 38554982 Free article.
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.
Corsi S, Scheggi S, Pardu A, Braccagni G, Caruso D, Cioffi L, Diviccaro S, Gentile M, Fanni S, Stancampiano R, Gambarana C, Melcangi RC, Frau R, Carta M. Corsi S, et al. Among authors: melcangi rc. Exp Neurol. 2023 May;363:114370. doi: 10.1016/j.expneurol.2023.114370. Epub 2023 Mar 5. Exp Neurol. 2023. PMID: 36878398 Free article.
Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].
Corsi S, Scheggi S, Pardu A, Braccagni G, Caruso D, Cioffi L, Diviccaro S, Gentile M, Fanni S, Stancampiano R, Gambarana C, Melcangi RC, Frau R, Carta M. Corsi S, et al. Among authors: melcangi rc. Exp Neurol. 2024 Mar;373:114640. doi: 10.1016/j.expneurol.2023.114640. Epub 2023 Dec 15. Exp Neurol. 2024. PMID: 38104017 No abstract available.
Effect of 5-alpha reductase inhibitors in animal models of Parkinson's disease.
Bourque M, Morissette M, Isenbrandt A, Giatti S, Melcangi RC, Carta M, Frau R, Bortolato M, Soulet D, Di Paolo T. Bourque M, et al. Among authors: melcangi rc. Front Neuroendocrinol. 2024 Oct;75:101156. doi: 10.1016/j.yfrne.2024.101156. Epub 2024 Sep 29. Front Neuroendocrinol. 2024. PMID: 39353534 Free article. Review.
The gut-microbiota-brain axis: Focus on gut steroids.
Diviccaro S, Giatti S, Cioffi L, Chrostek G, Melcangi RC. Diviccaro S, et al. Among authors: melcangi rc. J Neuroendocrinol. 2024 Nov 22:e13471. doi: 10.1111/jne.13471. Online ahead of print. J Neuroendocrinol. 2024. PMID: 39575839 Review.
221 results